On March 21, 2022 Pfizer announced a voluntary recall of several lots of its blood pressure medication Accuretic along with two generic versions of the drug - quinapril and hydrochlorothiazide and quinapril HCI/hydrochlorothiazide. The Accuretic recall was initiated after unsafe levels of a nitrosamine, N-nitroso-quinapril, were detected in the medications. Long term exposure to levels of nitrosamines above the FDA’s Acceptable Daily Intake level is linked to cancer. The nitrosamine N-nitrosodimethylamine (NDMA) was previously detected in dangerously highly levels in Zantac and Valsartan, which ultimately led to recalls of both medications.
The Accuretic recall covers six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets, and four lots of quinapril HCI/hydrochlorothiazide tablets. The recalled Accuretic and quinapril products were distributed in the US from November 2019 to March 2022.
Full information on the lots recalled can be found below.
Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg
Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg
Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg
NDC | Lot Number | Expiration Date | Strength | Configuration/Count |
0071-3112-23 | FG5379 | 08/2024 | 10/12.5 mg | 1 x 90 count bottle |
0071-0222-23 | EA6686 | 04/2022 | 10/12.5 mg | 1 x 90 count bottle |
0071-5212-23 | FG5381 | 08/2024 | 20/12.5 mg | 1 x 90 count bottle |
0071-0220-23 | EA6665 | 04/2022 | 20/12.5 mg | 1 x 90 count bottle |
0071-0220-23 | CN0640 | 04/2022 | 20/12.5 mg | 1 x 90 count bottle |
0071-0223-23 | ET6974 | 02/2023 | 20/25 mg | 1 x 90 count bottle |
quinapril and hydrochlorothiazide tablets, 20/25 mg
quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg
quinapril HCl/hydrochlorothiazide tablets, 20/25 mg
NDC | Lot Number | Expiration Date | Strength | Configuration/Count |
59762-5225-9 | FE3714 | 02/2023 | 20/25 mg | 1 x 90 count bottle |
59762-0220-1 | DN6931 | 03/2023 | 20/12.5 mg | 1 x 90 count bottle |
59762-0220-1 | ED3904 | 03/2023 | 20/12.5 mg | 1 x 90 count bottle |
59762-0220-1 | ED3905 | 03/2023 | 20/12.5 mg | 1 x 90 count bottle |
59762-0223-1 | DP3414 | 02/2023 | 20/25 mg | 1 x 90 count bottle |
GoldenbergLaw is representing hundreds of individuals who have been diagnosed with cancer due to nitrosamine contamination of medications. Our Accuretic recall attorneys have over 35 years of experience litigating defective drug claims and helping victims recover the compensation they deserve.
If you or a loved one has taken Accuretic or quinapril and received a recall letter or been diagnosed with cancer, contact our Minneapolis cancer attorneys today for a free consultation.
